Abstract
EDITOR,—We can confirm Ray King and Jonathan Denne's findings of an increased use of low dose aspirin in secondary prevention of cardiovascular disease1 and have a suggestion for why there may be a difference in the prevalence of such treatment between the sexes and how this might be overcome. Throughout 1994 and 1995 the Burn Brae Medical Group, a practice of six partners with 8200 patients in a market town, carried out three audits of the subject. A computer search followed …

This publication has 1 reference indexed in Scilit: